CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma

被引：0
|
作者：
Zeyana, Rivera [1 ]
Ferrone, Soldano [2 ,3 ,4 ]
Wang, Xinhui [2 ,3 ,4 ]
Sandro, Jube [1 ]
Yang, Haining [1 ]
Gaudino, Giovanni [1 ]
Carbone, Michele [1 ]
机构：
[1] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA
[2] Univ Pittsburgh, Dept Surg, Inst Canc, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Immunol, Inst Canc, Pittsburgh, PA USA
[4] Univ Pittsburgh, Dept Pathol, Inst Canc, Pittsburgh, PA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2514
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma
    Rivera, Zeyana
    Ferrone, Soldano
    Wang, Xinhui
    Jube, Sandro
    Yang, Haining
    Pass, Harvey I.
    Kanodia, Shreya
    Gaudino, Giovanni
    Carbone, Michele
    CLINICAL CANCER RESEARCH, 2012, 18 (19) : 5352 - 5363
  • [2] CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
    Wang, Xinhui
    Osada, Takuya
    Wang, Yangyang
    Yu, Ling
    Sakakura, Koichi
    Katayama, Akihiro
    McCarthy, James B.
    Brufsky, Adam
    Chivukula, Mamatha
    Khoury, Thaer
    Hsu, David S.
    Barry, William T.
    Lyerly, H. Kim
    Clay, Timothy M.
    Ferrone, Soldano
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (19): : 1496 - 1512
  • [3] Antibody-based immunotherapy: targeting CSPG4 on human basal breast cancer stem cells
    Wang, X.
    Osada, T.
    Wang, Y.
    Miyazato, P.
    Thorne, S.
    DeLeo, A.
    Lyerly, H. K.
    Clay, T.
    Ferrone, S.
    CANCER RESEARCH, 2009, 69 (02) : 314S - 315S
  • [4] CSPG4 monoclonal antibodies inhibit the growth of human malignant mesothelioma
    Zeyana, Rivera
    Ferrone, Soldano
    Wang, Xinhui
    Jube, Sandro
    Yang, Haining
    Gaudino, Giovanni
    Carbone, Michele
    CANCER RESEARCH, 2011, 71
  • [5] CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma
    Price, Matthew A.
    Wanshura, Leah E. Colvin
    Yang, Jianbo
    Carlson, Jennifer
    Xiang, Bo
    Li, Guiyuan
    Ferrone, Soldano
    Dudek, Arkadiusz Z.
    Turley, Eva A.
    McCarthy, James B.
    PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (06) : 1148 - 1157
  • [6] Antibody-Based Immunotherapy for Malignant Glioma
    Gedeon, Patrick C.
    Riccione, Katherine A.
    Fecci, Peter E.
    Sampson, John H.
    SEMINARS IN ONCOLOGY, 2014, 41 (04) : 496 - 510
  • [7] CSPG4: a prototype oncoantigen for translational immunotherapy studies
    Rolih, Valeria
    Barutello, Giuseppina
    Iussich, Selina
    De Maria, Raffaella
    Quaglino, Elena
    Buracco, Paolo
    Cavallo, Federica
    Riccardo, Federica
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [8] CSPG4: a prototype oncoantigen for translational immunotherapy studies
    Valeria Rolih
    Giuseppina Barutello
    Selina Iussich
    Raffaella De Maria
    Elena Quaglino
    Paolo Buracco
    Federica Cavallo
    Federica Riccardo
    Journal of Translational Medicine, 15
  • [9] Chondroitin sulfate proteoglycan 4: An attractive target for antibody-based immunotherapy
    Kurokawa, Tomohiro
    Imai, Kohzoh
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2024, 100 (05): : 293 - 308
  • [10] CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer
    Egan, Caitlin E.
    Stefanova, Dessislava
    Ahmed, Adnan
    Raja, Vijay J.
    Thiesmeyer, Jessica W.
    Chen, Kevin J.
    Greenberg, Jacques A.
    Zhang, Taotao
    He, Bing
    Finnerty, Brendan M.
    Zarnegar, Rasa
    Jin, Moonsoo M.
    Scognamiglio, Theresa
    Dephoure, Noah
    Fahey, Thomas, III
    Min, Irene M.
    THYROID, 2021, 31 (10) : 1481 - 1493
12345